Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 309

1.

Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2.

Boot E, Butcher NJ, Udow S, Marras C, Mok KY, Kaneko S, Barrett MJ, Prontera P, Berman BD, Masellis M, Dufournet B, Nguyen K, Charles P, Mutez E, Danaila T, Jacquette A, Colin O, Drapier S, Borg M, Fiksinski AM, Vergaelen E, Swillen A, Vogels A, Plate A, Perandones C, Gasser T, Clerinx K, Bourdain F, Mills K, Williams NM, Wood NW, Booij J, Lang AE, Bassett AS; International Research Group on 22q11.2DS-associated Parkinson's Disease.

Neurology. 2018 May 11. pii: 10.1212/WNL.0000000000005660. doi: 10.1212/WNL.0000000000005660. [Epub ahead of print]

PMID:
29752303
2.

Effects of Intravenous Thyrotropin Releasing Hormone on 18F-Fluorodeoxyglucose Uptake in Human Brown Adipose Tissue: A Randomized Controlled Trial.

Heinen CA, Zhang Z, Klieverik LP, de Wit TC, Poel E, Yaqub M, Boelen A, Kalsbeek A, Bisschop PH, van Trotsenburg P, Verberne H, Booij J, Fliers E.

Eur J Endocrinol. 2018 May 3. pii: EJE-17-0966. doi: 10.1530/EJE-17-0966. [Epub ahead of print]

PMID:
29724865
3.

Striatal dopamine release and impaired reinforcement learning in adults with 22q11.2 deletion syndrome.

van Duin EDA, Kasanova Z, Hernaus D, Ceccarini J, Heinzel A, Mottaghy F, Mohammadkhani-Shali S, Winz O, Frank M, Beck MCH, Booij J, Myin-Germeys I, van Amelsvoort T.

Eur Neuropsychopharmacol. 2018 Apr 24. pii: S0924-977X(18)30068-3. doi: 10.1016/j.euroneuro.2018.03.005. [Epub ahead of print]

PMID:
29703646
4.

Relationship between muscarinic M1 receptor binding and cognition in medication-free subjects with psychosis.

Bakker G, Vingerhoets C, Boucherie D, Caan M, Bloemen O, Eersels J, Booij J, van Amelsvoort T.

Neuroimage Clin. 2018 Mar 3;18:713-719. doi: 10.1016/j.nicl.2018.02.030. eCollection 2018.

5.

Relationships between Serotonin Transporter Binding in the Raphe Nuclei, Basal Ganglia, and Hippocampus with Clinical Symptoms in Cervical Dystonia: A [11C]DASB Positron Emission Tomography Study.

Smit M, Vállez García D, de Jong BM, Zoons E, Booij J, Dierckx RA, Willemsen AT, de Vries EF, Bartels AL, Tijssen MA.

Front Neurol. 2018 Feb 28;9:88. doi: 10.3389/fneur.2018.00088. eCollection 2018.

6.

Performance evaluation of a novel brain-dedicated SPECT system.

Stam MK, Verwer EE, Booij J, Adriaanse SM, de Bruin CM, de Wit TC.

EJNMMI Phys. 2018 Mar 1;5(1):4. doi: 10.1186/s40658-018-0203-1. No abstract available.

7.

Randomised controlled trial of escitalopram for cervical dystonia with dystonic jerks/tremor.

Zoons E, Booij J, Delnooz CCS, Dijk JM, Dreissen YEM, Koelman JHTM, van der Salm SMA, Skorvanek M, Smit M, Aramideh M, Bienfait H, Boon AJW, Brans JWM, Hoogerwaard E, Hovestadt A, Kamphuis DJ, Munts AG, Speelman JD, Tijssen MAJ.

J Neurol Neurosurg Psychiatry. 2018 Jan 11. pii: jnnp-2017-317352. doi: 10.1136/jnnp-2017-317352. [Epub ahead of print]

PMID:
29326295
8.

Intact striatal dopaminergic modulation of reward learning and daily-life reward-oriented behavior in first-degree relatives of individuals with psychotic disorder.

Kasanova Z, Ceccarini J, Frank MJ, van Amelsvoort T, Booij J, van Duin E, Steinhart H, Vaessen T, Heinzel A, Mottaghy F, Myin-Germeys I.

Psychol Med. 2017 Dec 13:1-6. doi: 10.1017/S0033291717003476. [Epub ahead of print]

PMID:
29233195
9.

Novel molecular imaging ligands targeting matrix metalloproteinases 2 and 9 for imaging of unstable atherosclerotic plaques.

Hakimzadeh N, Pinas VA, Molenaar G, de Waard V, Lutgens E, van Eck-Smit BLF, de Bruin K, Piek JJ, Eersels JLH, Booij J, Verberne HJ, Windhorst AD.

PLoS One. 2017 Nov 30;12(11):e0187767. doi: 10.1371/journal.pone.0187767. eCollection 2017.

10.

Dopamine in high-risk populations: A comparison of subjects with 22q11.2 deletion syndrome and subjects at ultra high-risk for psychosis.

Vingerhoets C, Bloemen OJN, Boot E, Bakker G, de Koning MB, da Silva Alves F, Booij J, van Amelsvoort TAMJ.

Psychiatry Res Neuroimaging. 2018 Feb 28;272:65-70. doi: 10.1016/j.pscychresns.2017.11.014. Epub 2017 Nov 21.

PMID:
29174435
11.

Lower serotonin transporter binding in patients with cervical dystonia is associated with psychiatric symptoms.

Zoons E, Booij J, Speelman JD, Dreissen YEM, Smit M, Tijssen MAJ.

EJNMMI Res. 2017 Oct 25;7(1):87. doi: 10.1186/s13550-017-0338-4.

12.

The role of central dopamine and serotonin in human obesity: lessons learned from molecular neuroimaging studies.

van Galen KA, Ter Horst KW, Booij J, la Fleur SE, Serlie MJ.

Metabolism. 2017 Sep 29. pii: S0026-0495(17)30251-2. doi: 10.1016/j.metabol.2017.09.007. [Epub ahead of print] Review.

PMID:
28970033
13.

Serotonin transporter binding and anxiety symptoms in Parkinson's disease.

Joling M, van den Heuvel OA, Berendse HW, Booij J, Vriend C.

J Neurol Neurosurg Psychiatry. 2018 Jan;89(1):89-94. doi: 10.1136/jnnp-2017-316193. Epub 2017 Sep 12.

PMID:
28899958
14.

FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder.

Meles SK, Vadasz D, Renken RJ, Sittig-Wiegand E, Mayer G, Depboylu C, Reetz K, Overeem S, Pijpers A, Reesink FE, van Laar T, Heinen L, Teune LK, Höffken H, Luster M, Kesper K, Adriaanse SM, Booij J, Leenders KL, Oertel WH.

Mov Disord. 2017 Oct;32(10):1482-1486. doi: 10.1002/mds.27094. Epub 2017 Jul 22.

15.

The effect of the muscarinic M1 receptor antagonist biperiden on cognition in medication free subjects with psychosis.

Vingerhoets C, Bakker G, van Dijk J, Bloemen OJN, Wang Y, Chan RCK, Booij J, van Amelsvoort TAMJ.

Eur Neuropsychopharmacol. 2017 Sep;27(9):854-864. doi: 10.1016/j.euroneuro.2017.06.014. Epub 2017 Jul 6.

PMID:
28689687
16.

Timing of caloric intake during weight loss differentially affects striatal dopamine transporter and thalamic serotonin transporter binding.

Versteeg RI, Schrantee A, Adriaanse SM, Unmehopa UA, Booij J, Reneman L, Fliers E, la Fleur SE, Serlie MJ.

FASEB J. 2017 Oct;31(10):4545-4554. doi: 10.1096/fj.201601234R. Epub 2017 Jul 5.

PMID:
28679529
17.

Cerebral dopamine deficiency, plasma monoamine alterations and neurocognitive deficits in adults with phenylketonuria.

Boot E, Hollak CEM, Huijbregts SCJ, Jahja R, van Vliet D, Nederveen AJ, Nieman DH, Bosch AM, Bour LJ, Bakermans AJ, Abeling NGGM, Bassett AS, van Amelsvoort TAMJ, van Spronsen FJ, Booij J.

Psychol Med. 2017 May 29:1-12. doi: 10.1017/S0033291717001398. [Epub ahead of print]

PMID:
28552082
18.

Diagnostic Performance of the Visual Reading of 123I-Ioflupane SPECT Images With or Without Quantification in Patients With Movement Disorders or Dementia.

Booij J, Dubroff J, Pryma D, Yu J, Agarwal R, Lakhani P, Kuo PH.

J Nucl Med. 2017 Nov;58(11):1821-1826. doi: 10.2967/jnumed.116.189266. Epub 2017 May 4.

PMID:
28473597
19.

18F-FDG uptake in the colon is modulated by metformin but not associated with core body temperature and energy expenditure.

Bahler L, Holleman F, Chan MW, Booij J, Hoekstra JB, Verberne HJ.

PLoS One. 2017 May 2;12(5):e0176242. doi: 10.1371/journal.pone.0176242. eCollection 2017.

20.

Striatal dopaminergic modulation of reinforcement learning predicts reward-oriented behavior in daily life.

Kasanova Z, Ceccarini J, Frank MJ, Amelsvoort TV, Booij J, Heinzel A, Mottaghy F, Myin-Germeys I.

Biol Psychol. 2017 Jul;127:1-9. doi: 10.1016/j.biopsycho.2017.04.014. Epub 2017 Apr 29.

PMID:
28461214
21.

QT prolongation by dexamphetamine: Does experience matter?

Schrantee A, Václavů L, Reneman L, Verberne HJ, Booij J, Tan HL.

J Cardiovasc Electrophysiol. 2017 Aug;28(8):912-916. doi: 10.1111/jce.13235. Epub 2017 Jun 21.

PMID:
28452189
22.

The relationship between the dopaminergic system and depressive symptoms in cervical dystonia.

Zoons E, Tijssen MAJ, Dreissen YEM, Speelman JD, Smit M, Booij J.

Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1375-1382. doi: 10.1007/s00259-017-3664-x. Epub 2017 Mar 17.

23.

Repeated dexamphetamine treatment alters the dopaminergic system and increases the phMRI response to methylphenidate.

Schrantee A, Tremoleda JL, Wylezinska-Arridge M, Bouet V, Hesseling P, Meerhoff GF, de Bruin KM, Koeleman J, Freret T, Boulouard M, Desfosses E, Galineau L, Gozzi A, Dauphin F, Gsell W, Booij J, Lucassen PJ, Reneman L.

PLoS One. 2017 Feb 27;12(2):e0172776. doi: 10.1371/journal.pone.0172776. eCollection 2017.

24.

Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.

Doppler K, Jentschke HM, Schulmeyer L, Vadasz D, Janzen A, Luster M, Höffken H, Mayer G, Brumberg J, Booij J, Musacchio T, Klebe S, Sittig-Wiegand E, Volkmann J, Sommer C, Oertel WH.

Acta Neuropathol. 2017 Apr;133(4):535-545. doi: 10.1007/s00401-017-1684-z. Epub 2017 Feb 8.

25.

[123I]FP-CIT ENC-DAT normal database: the impact of the reconstruction and quantification methods.

Tossici-Bolt L, Dickson JC, Sera T, Booij J, Asenbaun-Nan S, Bagnara MC, Borght TV, Jonsson C, de Nijs R, Hesse S, Koulibaly PM, Akdemir UO, Koole M, Tatsch K, Varrone A.

EJNMMI Phys. 2017 Dec;4(1):8. doi: 10.1186/s40658-017-0175-6. Epub 2017 Jan 28.

26.

The impact of reconstruction and scanner characterisation on the diagnostic capability of a normal database for [123I]FP-CIT SPECT imaging.

Dickson JC, Tossici-Bolt L, Sera T, Booij J, Ziebell M, Morbelli S, Assenbaum-Nan S, Borght TV, Pagani M, Kapucu OL, Hesse S, Van Laere K, Darcourt J, Varrone A, Tatsch K.

EJNMMI Res. 2017 Dec;7(1):10. doi: 10.1186/s13550-016-0253-0. Epub 2017 Jan 24.

27.

Hot heads & cool bodies: The conundrums of human brown adipose tissue (BAT) activity research.

Bahler L, Holleman F, Booij J, Hoekstra JB, Verberne HJ.

Eur J Intern Med. 2017 May;40:26-29. doi: 10.1016/j.ejim.2016.12.023. Epub 2017 Jan 5. Review.

PMID:
28065662
28.

Biological Mechanisms Whereby Social Exclusion May Contribute to the Etiology of Psychosis: A Narrative Review.

Selten JP, Booij J, Buwalda B, Meyer-Lindenberg A.

Schizophr Bull. 2017 Jan 3. pii: sbw180. doi: 10.1093/schbul/sbw180. [Epub ahead of print]

29.

Erratum to: The need of standardization and of large clinical studies in an emerging indication of [18 F]FDG PET: the autoimmune encephalitis.

Morbelli S, Arbizu J, Booij J, Chen MK, Chetelat G, Cross DJ, Djekidel M, Drzezga A, Ekmekcioglu O, Garibotto V, Hesse S, Ishii K, Jafari L, Lammertsma AA, Law I, Mathews D, Minoshima S, Mosci K, Pagani M, Pappata S, Silverman DH, Signore A, Van De Giessen E, Villemagne V, Barthel H; European Association of Nuclear Medicine (EANM) and of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):559-560. doi: 10.1007/s00259-016-3598-8. No abstract available.

PMID:
27987029
30.

The need of standardization and of large clinical studies in an emerging indication of [18F]FDG PET: the autoimmune encephalitis.

Morbelli S, Arbizu J, Booij J, Chen MK, Chetelat G, Cross DJ, Djekidel M, Drzezga A, Ekmekcioglu O, Garibotto V, Hesse S, Ishii K, Jafari L, Lammertsma AA, Law I, Mathews D, Minoshima S, Mosci K, Pagani M, Pappata S, Silverman DH, Signore A, Van De Giessen E, Villemagne V, Barthel H; European Association of Nuclear Medicine (EANM) and of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):353-357. doi: 10.1007/s00259-016-3589-9. Epub 2016 Dec 6. No abstract available. Erratum in: Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):559-560. Saraf LJ [corrected to Jafari L].

PMID:
27924371
31.

Reactivity to social stress in ethnic minority men.

Gevonden M, Myin-Germeys I, Wichers M, Booij J, van den Brink W, van Winkel R, Selten JP.

Psychiatry Res. 2016 Dec 30;246:629-636. doi: 10.1016/j.psychres.2016.10.076. Epub 2016 Nov 2.

PMID:
27884461
32.

Analysis of Extrastriatal 123I-FP-CIT Binding Contributes to the Differential Diagnosis of Parkinsonian Diseases.

Joling M, Vriend C, van den Heuvel OA, Raijmakers PGHM, Jones PA, Berendse HW, Booij J.

J Nucl Med. 2017 Jul;58(7):1117-1123. doi: 10.2967/jnumed.116.182139. Epub 2016 Nov 17.

PMID:
27856628
33.

Cortical Morphology Differences in Subjects at Increased Vulnerability for Developing a Psychotic Disorder: A Comparison between Subjects with Ultra-High Risk and 22q11.2 Deletion Syndrome.

Bakker G, Caan MW, Vingerhoets WA, da Silva-Alves F, de Koning M, Boot E, Nieman DH, de Haan L, Bloemen OJ, Booij J, van Amelsvoort TA.

PLoS One. 2016 Nov 9;11(11):e0159928. doi: 10.1371/journal.pone.0159928. eCollection 2016.

34.

Bromocriptine and insulin sensitivity in lean and obese subjects.

Bahler L, Verberne HJ, Brakema E, Tepaske R, Booij J, Hoekstra JB, Holleman F.

Endocr Connect. 2016 Nov;5(6):44-52. Epub 2016 Oct 10.

35.

Serotonin Transporter Binding in the Diencephalon Is Reduced in Insulin-Resistant Obese Humans.

Versteeg RI, Koopman KE, Booij J, Ackermans MT, Unmehopa UA, Fliers E, la Fleur SE, Serlie MJ.

Neuroendocrinology. 2017;105(2):141-149. doi: 10.1159/000450549. Epub 2016 Sep 14.

36.

Acceptability of Extended-Release Naltrexone by Heroin-Dependent Patients and Addiction Treatment Providers in the Netherlands.

Zaaijer ER, Goudriaan AE, Koeter MW, Booij J, van den Brink W.

Subst Use Misuse. 2016 Dec 5;51(14):1905-11. doi: 10.1080/10826084.2016.1201117. Epub 2016 Sep 9.

PMID:
27613150
37.

The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies.

Vegting Y, Reneman L, Booij J.

Psychopharmacology (Berl). 2016 Oct;233(19-20):3473-501. doi: 10.1007/s00213-016-4396-5. Epub 2016 Aug 28. Review.

38.

Corrigendum to "Cardiac sympathetic activity in 22q11.2 deletion syndrome" [Int. J. Cardiol. 212 (2016) 346-351].

Verschure DO, Boot E, van Amelsvoort TA, Booij J, van Eck-Smit BLF, Somsen GA, Verberne HJ.

Int J Cardiol. 2016 Nov 1;222:1141. doi: 10.1016/j.ijcard.2016.06.055. Epub 2016 Jun 30. No abstract available.

PMID:
27373741
39.

Dopaminergic Effects on Brown Adipose Tissue (DEBAT): A prospective physiological study.

Bahler L, Verberne HJ, Soeters MR, Booij J, Hoekstra JB, Holleman F.

Diabetes Metab. 2017 Apr;43(2):172-175. doi: 10.1016/j.diabet.2016.06.003. Epub 2016 Jun 29. No abstract available.

PMID:
27372402
40.

Unilateral Maxillary First Molar Extraction in Class II Subdivision: An Unconventional Treatment Alternative.

Booij JW, Livas C.

Case Rep Dent. 2016;2016:2168367. doi: 10.1155/2016/2168367. Epub 2016 Apr 21.

41.

Distinct white-matter aberrations in 22q11.2 deletion syndrome and patients at ultra-high risk for psychosis.

Bakker G, Caan MW, Schluter RS, Bloemen OJ, da Silva-Alves F, de Koning MB, Boot E, Vingerhoets WA, Nieman DH, de Haan L, Booij J, van Amelsvoort TA.

Psychol Med. 2016 Aug;46(11):2299-311. doi: 10.1017/S0033291716000970. Epub 2016 May 19.

PMID:
27193339
42.

Striatal dopamine D2/3 receptor availability increases after long-term bariatric surgery-induced weight loss.

van der Zwaal EM, de Weijer BA, van de Giessen EM, Janssen I, Berends FJ, van de Laar A, Ackermans MT, Fliers E, la Fleur SE, Booij J, Serlie MJ.

Eur Neuropsychopharmacol. 2016 Jul;26(7):1190-200. doi: 10.1016/j.euroneuro.2016.04.009. Epub 2016 May 12.

PMID:
27184782
43.

Cardiac sympathetic activity in 22q11.2 deletion syndrome.

Verschure DO, Boot E, van Amelsvoort TA, Booij J, van Eck-Smit BL, Somsen GA, Verberne HJ.

Int J Cardiol. 2016 Jun 1;212:346-51. doi: 10.1016/j.ijcard.2016.03.185. Epub 2016 Mar 25. Erratum in: Int J Cardiol. 2016 Nov 1;222:1141.

PMID:
27057952
44.

Brain dopamine and serotonin transporter binding are associated with visual attention bias for food in lean men.

Koopman KE, Roefs A, Elbers DC, Fliers E, Booij J, Serlie MJ, la Fleur SE.

Psychol Med. 2016 Jun;46(8):1707-17. doi: 10.1017/S0033291716000222. Epub 2016 Mar 17.

PMID:
26984412
45.

Quantitative agreement between [(15)O]H2O PET and model free QUASAR MRI-derived cerebral blood flow and arterial blood volume.

Heijtel DF, Petersen ET, Mutsaerts HJ, Bakker E, Schober P, Stevens MF, van Berckel BN, Majoie CB, Booij J, van Osch MJ, van Bavel ET, Boellaard R, Lammertsma AA, Nederveen AJ.

NMR Biomed. 2016 Apr;29(4):519-26. doi: 10.1002/nbm.3480. Epub 2016 Feb 15.

PMID:
26876426
46.

[(123)]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies.

van der Zande JJ, Booij J, Scheltens P, Raijmakers PG, Lemstra AW.

Eur J Nucl Med Mol Imaging. 2016 Jun;43(6):1060-6. doi: 10.1007/s00259-016-3312-x. Epub 2016 Jan 30.

47.

Identification of Pseudomonas aeruginosa and Aspergillus fumigatus mono- and co-cultures based on volatile biomarker combinations.

Neerincx AH, Geurts BP, Habets MF, Booij JA, van Loon J, Jansen JJ, Buydens LM, van Ingen J, Mouton JW, Harren FJ, Wevers RA, Merkus PJ, Cristescu SM, Kluijtmans LA.

J Breath Res. 2016 Jan 29;10(1):016002. doi: 10.1088/1752-7155/10/1/016002.

PMID:
26824272
48.

Reduction in camera-specific variability in [(123)I]FP-CIT SPECT outcome measures by image reconstruction optimized for multisite settings: impact on age-dependence of the specific binding ratio in the ENC-DAT database of healthy controls.

Buchert R, Kluge A, Tossici-Bolt L, Dickson J, Bronzel M, Lange C, Asenbaum S, Booij J, Atay Kapucu LÖ, Svarer C, Koulibaly PM, Nobili F, Pagani M, Sabri O, Sera T, Tatsch K, Vander Borght T, Van Laere K, Varrone A, Iida H.

Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1323-36. doi: 10.1007/s00259-016-3309-5. Epub 2016 Jan 27.

PMID:
26816194
49.

Does fixed retention prevent overeruption of unopposed mandibular second molars in maxillary first molar extraction cases?

Livas C, Halazonetis DJ, Booij JW, Katsaros C, Ren Y.

Prog Orthod. 2016;17:6. doi: 10.1186/s40510-016-0119-z. Epub 2016 Jan 21.

50.

Implementation of the European multicentre database of healthy controls for [(123)I]FP-CIT SPECT increases diagnostic accuracy in patients with clinically uncertain parkinsonian syndromes.

Albert NL, Unterrainer M, Diemling M, Xiong G, Bartenstein P, Koch W, Varrone A, Dickson JC, Tossici-Bolt L, Sera T, Asenbaum S, Booij J, Kapucu LÖ, Kluge A, Ziebell M, Darcourt J, Nobili F, Pagani M, Sabri O, Hesse S, Borght TV, Van Laere K, Tatsch K, la Fougère C.

Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1315-22. doi: 10.1007/s00259-015-3304-2. Epub 2016 Jan 18.

PMID:
26780619

Supplemental Content

Support Center